Objective The present study was conducted using data accumulated from our earlier study of bleeding peptic ulcers, focusing on elderly patients. Methods A total of 461 patients with bleeding peptic ulcers underwent emergency endoscopy at Saga Medical School Hospital between 1999 and 2011. Risk factors for bleeding peptic ulcers were compared between two groups: an elderly group (! 65 years old) and a nonelderly group (<65 years old). The relationship between drug use and age was examined using multiple logistic regression models. In the elderly group, the factors were compared between Period I (1999Period I ( -2005 and Period II (2006II ( -2011. Results The proportion of men and the incidence of Helicobacter pylori infection were lower in the elderly group than in the nonelderly group. The use of low-dose aspirin, antithrombotic drugs and corticosteroids, but not nonsteroidal anti-inflammatory drugs, was higher in the elderly group. A multiple logistic regression analysis of prescribed medications indicated that low-dose aspirin was more frequently used in the elderly group. The rate of comorbidities was higher and the hemoglobin levels were lower in the elderly group. The rates of rebleeding within one week and death within one month did not differ in the elderly group. Compared with that observed in Period I, the incidence of Helicobacter pylori infection was decreased and the rate of comorbidities was increased in Period II. Conclusion This study indicates that factors related to bleeding peptic ulcers in elderly patients have shifted from Helicobacter pylori infection to comorbidities associated with low-dose aspirin, suggesting a close relationship between low-dose aspirin therapy and comorbidities in elderly patients with peptic ulcers.
Introduction
It is well documented that Helicobacter pylori infection is one of the most important causes of peptic ulcers (1) (2) (3) . Nonsteroidal anti-inflammatory drugs (NSAIDs), aspirin and corticosteroids are important and exacerbating factors of bleeding peptic ulcers (4) (5) (6) . With the recent rise in the number of elderly individuals, the rate of comorbidities, including cardiovascular diseases, cerebral vascular diseases and orthopedic diseases, has been markedly increasing in Japan.
with peptic ulcers (7) (8) (9) (10) (11) .
The aim of this study was to clarify the clinical characteristics of elderly patients with bleeding peptic ulcers in Japan. Patients who underwent emergency endoscopy for bleeding peptic ulcers at Saga Medical School Hospital between 1999 and 2011 were divided into two groups according to age (nonelderly group, <65 years old; elderly group, " 65 years old) in order to compare their demographic characteristics. In addition, the elderly group was analyzed in a time-dependent manner with respect to Period I (1999 Period I ( -2005 and Period II (2006) (2007) (2008) (2009) (2010) (2011) in order to evaluate whether the tendency of hemorrhagic peptic ulcer development in elderly patients has changed over time.
Materials and Methods
The subjects in the present study were recruited from among patients who underwent upper gastrointestinal emergency endoscopy at the Saga Medical School Hospital between January 1999 and December 2011. Emergency endoscopy was defined as the use of endoscopy within 24 hours in patients suspected of having upper gastrointestinal bleeding based on symptoms of hematemesis, melena and/or rapidly progressing anemia. All patients who were found to have bleeding gastric and/or duodenal ulcers were enrolled in the present study, including both patients who did not require endoscopic hemostasis and patients who did require endoscopic hemostasis with endoscopic maneuvers, such as the use of hemoclips, pure ethanol injection and/or electrocoagulation. All patients were hospitalized and managed conventionally using intravenous fluids and proton pump inhibitors or histamine H2-receptor antagonists without oral feeding. Within 48 hours after emergency endoscopy, the patients underwent follow-up endoscopy, and complete hemostasis was confirmed. H. pylori infection was diagnosed using rapid urease tests of the biopsy specimens (Helicocheck; Otsuka Pharmaceuticals, Tokyo, Japan) and 13 C-urea breath tests (UBTs). The UBTs were performed 48 to 72 hours after the first emergency endoscopy. The samples were analyzed using UBiT (UBiT-IR300; Otsuka Pharmaceuticals) with a cutoff value of <2.5‰. In patients identified as being H. pylori-negative after the initial evaluation, serological tests were performed to detect anti-H. pylori immunoglobulin G (IgG) using an anti-H. pylori IgG assay kit (E-Plate anti-H. pylori IgG; Eiken, Tokyo, Japan). When all three tests were negative, the patient was diagnosed as being H. pylori-negative. The patients and their family members were surveyed regarding the use of NSAIDs, including at least one occasional episode of drug intake occurring within one week before emergency endoscopy. The use of NSAID suppositories or patches was not included. All doctors and nurses involved in the study were independently educated regarding the investigation of the patient's underlying disease and medications, including OTC drugs, using a questionnaire prepared in advance. If they were unable to obtain the proper information from the patient, they consulted the patient's physician. Low-dose aspirin therapy was defined as the intake of ! 300 mg of aspirin in one day, not including NSAIDs or antithrombotic drugs in the present analysis.
The statistical analyses were performed using the Statistical Analysis System (SAS) version 9.1 software program (SAS Institute, Cary, USA). The patients were divided into two groups according to age (nonelderly group, <65 years; elderly group, " 65 years) in order to analyze the characteristics of bleeding peptic ulcers in elderly patients. The incidences of H. pylori infection, use of low-dose aspirin, NSAIDs, antithrombotic drugs and corticosteroids, comorbidities, rebleeding within one week and death within one month, the hemoglobin levels on the day of hospitalization and the amount of transfusion required were compared between the two groups using the chi-square test or Student's t-test, as appropriate. In addition, the patients in the elderly group were analyzed in a time-dependent manner with respect to Period I (1999 Period I ( -2005 and Period II (2006-2011) in order to evaluate whether the tendency of hemorrhagic peptic ulcer development in elderly patients has changed over time. The relationships between the use of each medicine and each age group (nonelderly group, <65 years old; elderly group, " 65 years old) were examined using a univariate logistic regression model (Model 1), and the odds ratios (ORs) and confidence intervals (CIs) for each factor in the elderly group were computed. Multivariate logistic regression models were used to evaluate the above associations with adjustment for potential confounders selected based on established risk factors for bleeding ulcers, such as drugs, H. pylori, sex, comorbidities. First, the analysis was adjusted for the use of the other medicines (Model 2). Regarding the association between the age group and the use of low dose aspirin, we adjusted the analysis for the use of NSAIDs, antithrombotic drugs and corticosteroids. Similarly, we adjusted for the use of low-dose aspirin, antithrombotic drugs and corticosteroids in the association with the use of NSAIDs, we adjusted for the use of low-dose aspirin, NSAIDs and corticosteroids in the association with the use of antithrombotic drugs and we adjusted for the use of lowdose aspirin, NSAIDs and antithrombotic drugs in the association with the use of corticosteroids. Then, we additionally adjusted for H. pylori infection in Model 2 (Model 3), sex in Model 3 (Model 4) and comorbidities in Model 4 (Model 5). Statistical significance was set at p<0.05.
Results
Between January 1999 and December 2011, we encountered 461 patients with upper gastrointestinal bleeding who were confirmed to have bleeding peptic ulcers during emergency endoscopy. The characteristics of the patients are summarized in Table 1 . There were 327 (70.9%) men and 134 (29.1%) women, with a mean age of 62.9±16.8 years. As indicated, 343 (74.4%) patients had gastric ulcers, 112 (24.3%) patients had duodenal ulcers and six (1.3%) patients had both gastric and duodenal ulcers. All patients who re- Table 1 shows the age-related characteristics of bleeding peptic ulcers in the elderly versus nonelderly patients. The proportion of men in the elderly group was significantly lower than that observed in the nonelderly group (79.6% vs. 62.3%, p<0.001). Bleeding caused by duodenal ulcers was more frequently observed in the nonelderly patients. The rate of H. pylori infection was lower in the elderly patients (61.3% vs. 47.1%, p=0.0023). The rate of low-dose aspirin, antithrombotic drug and corticosteroid use was significantly higher in the elderly patients with bleeding peptic ulcers than in the nonelderly patients, whereas the rate of NSAID use did not differ between the two groups. The rate of comorbidities in the elderly patients (73.6%) was significantly higher than that observed in the nonelderly patients (41.7%, p=0.001) due to the high rates of cardiovascular disease, cerebrovascular disease, chronic pulmonary disease, orthopedic disease, hypertension, hyperlipidemia and diabetes mellitus. The hemoglobin levels on the day of hospitalization were lower in the elderly patients, although the blood transfusion volume did not differ between the two patient groups. The rates of rebleeding within one week and death within one month (8.7% and 3.5%, respectively) in the elderly patients did not differ significantly from those observed in the nonelderly patients (10.0% and 1.3%, respectively). The results of the comparison between the patients 65 to 80 years of age and those >81 years of age are shown in Ta- ble 2. None of the factors indicated in Table 2 differed between the patients 65 to 80 years of age (elderly group) and those >81 years of age (super-elderly group).
The relationships between medications that can exacerbate bleeding gastric and/or duodenal ulcers and age are shown in Table 3 . The rate of low-dose aspirin, antithrombotic drug and corticosteroid use was significantly higher in the elderly group than in the nonelderly group, whereas that of NSAIDs was not significantly different between the elderly and nonelderly groups (Model 1). Adjusting for each medicine did not substantially alter the results (Model 2). With additional adjustment for H. pylori infection (Model 3), the association between antithrombotic drugs and age disappeared. With further adjustment for sex, the association between the use of low-dose aspirin and an elderly age remained significant, although the association for corticosteroid use did not reach statistical significance (Model 4). The significant association with low-dose aspirin disappeared following further adjustment for comorbidities (Model 5).
The background characteristics of the elderly patients with bleeding peptic ulcers were compared between Period I (1999-2005) and Period II (2006-2011), as indicated in Table 4 . Compared with that observed in Period I, the H. pylori infection rate was decreased and the rate of comorbidities was increased in Period II (p=0.002 and p=0.011, respectively). The use of low-dose aspirin and the incidence of death within one month tended to increase in Period II; however, the trend was not significant in the elderly patients with bleeding peptic ulcers.
Discussion
The present study was conducted using continuously accumulated data obtained from our earlier studies (10, 11) and reflects the current Japanese situation in terms of the prevalence of bleeding peptic ulcers; i.e., this study focused on elderly patients with bleeding ulcers. In this study, drugs, H. pylori infection, sex and comorbidities were identified to be contributing factors for bleeding gastroduodenal ulcers in elderly patients, suggesting a close relationship between low-dose aspirin use and comorbidities.
Several studies have identified the use of NSAIDs, including low-dose aspirin, as being a significant cause of gastroduodenal ulcers (12) (13) (14) (15) (16) (17) (18) (19) . A large number of elderly people with cardiovascular disease, cerebrovascular disease and chronic joint pain have been prescribed low-dose aspirin, antithrombotic drugs, NSAIDs and corticosteroids for primary or secondary prevention of cardiovascular disease, cerebrovascular disorders and arthralgia (18) (19) (20) (21) (22) . In the present study, a univariate analysis focused on prescribed medications indicated that low-dose aspirin, antithrombotic drugs and corticosteroids are exacerbating factors for bleeding gastric and/or duodenal ulcers in elderly patients compared with nonelderly patients. The use of low-dose aspirin was closely related to an older age in the bleeding peptic ulcer patients. Low-dose aspirin prescribed for the primary and secondary prevention of vascular thromboembolism (23, 24) exacerbates gastrointestinal mucosal injury, including bleeding peptic ulcers (14, 18, 25, 26) . In addition, the adverse effects of low-dose aspirin are enhanced when combined with antithrombotic therapy (27) . In the present study, the proportion of women was higher in the elderly group than in the nonelderly group, consistent with an earlier study in Japan (28) . The main reason for this result may be the longer survival of women compared with men in Japan. The prevalence of H. pylori infection was decreased in the elderly patients with bleeding ulcers compared with that observed in the nonelderly patients. The prevalence of H. pylori increases in an age-related manner in the general population of Japan (29, 30) . It has been shown that low-dose aspirin is a significant factor for disease exacerbation in elderly patients with bleeding ulcers, and the advancement of gastric atrophy with age in individuals with H. pylori infection may be a protective factor for the development of bleeding ulcers (29, 31, 32) . The relationship between H. pylori infection and aspirin-related peptic ulcers is controversial. Some studies have indicated that H. pylori infection exacerbates aspirin-induced peptic ulcers that are reduced by eradication (20, 33, 34) , while other studies have reported that H. pylori infection is not a risk factor for the development of aspirin-induced peptic ulcers (34) (35) (36) . The results of the present study showing a decrease in the rate of H. pylori infection and an increase in the rate of aspirin use in elderly bleeding ulcer patients suggest that the risk of aspirin-induced bleeding is reduced in H. pylori-infected patients. The indications for eradication of H. pylori infection to treat aspirin-induced bleeding ulcers in elderly patients in Japan warrant further exploration.
In the present study, the outcomes of endoscopic hemostasis in the elderly patients were equivalent to those observed in the nonelderly patients. The mortality rate, transfusion volume and rebleeding rate were not significantly different between the elderly and nonelderly patients, although the hemoglobin levels on the day of hospitalization were lower in the elderly patients. In all 11 patients who died, the case of death was aggravation of comorbidities, including multiple organ failure with malignant diseases in five patients, liver failure in two patients, heart failure in two patients, pneumonia in one patient and a perforated colon diverticulum in one patient. Antithrombotic drugs and low-dose aspirin were discontinued in all patients who resumed oral ingestion following endoscopic hemostasis, and there were no deaths or complications due to withdrawal. Recent reports in Japan, including the present study, have shown that endoscopic hemostasis is the first indication for bleeding ulcers (37) (38) (39) (40) (41) . The rate of hemostasis has been reported to be >95% in Japan, resulting in decreased mortality rates and indications for surgical treatment (42) (43) (44) (45) .
In conclusion, the etiology of bleeding peptic ulcers in elderly patients in Japan has shifted from H. pylori infection toward comorbidities in patients prescribed medications, such as low-dose aspirin.
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